AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

WHI data prompt strict warnings on hormone products: black box warning must be added to all estrogen and estrogen-progesterone products. (Wyeth Revises Indications).

OB GYN News

| February 15, 2003 | Mechcatie, Elizabeth | COPYRIGHT 2003 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

ROCKVILLE, MD. -- A black box warning outlining the increased risks of heart disease, myocardial infarction, stroke, and breast cancer is now required in the labeling of all estrogen and estrogen-progesterone products.

The Food and Drug Administration last month announced the addition of the black box, the strongest warning that can be made in a drug label. The agency also revised two approved indications for these products and made other labeling changes.

The moves come as a result of an FDA analysis of the raw data from one arm of the Women's Health Initiative (WHI), which was published last summer. That part of the trial was halted 3 years early when the estrogen-progestin combination (Prempro) used in the study was linked to a doubling in the risk of pulmonary emboli and deep vein thrombosis and an increased risk of stroke, MI, invasive breast cancer, and total cardiovascular disease. The estrogen (Premarin)-only arm is continuing, and results are expected in 3 years.

The FDA also announced last month that it had approved new physician labeling and new patient information leaflets incorporating these changes for Wyeth's Prempro and Prem phase (conjugated estrogens/medroxyprogesterone) and Premarin (conjugated estrogens).

Furthermore, in letters sent to manufacturers of other currently available estrogen and estrogen-progesterone products, "all manufacturers are being asked to revise their labeling in a similar fashion," said Dr. Florence Houn, director of the FDA's Office of Drug Evaluation III, in the Centers for Drugs Evaluation and Research.

Dr. Wulf Utian, executive director of the North American Menopause Society said in an interview that the FDA's application of the changes to all estrogen and estrogen-progestin products is "quite reasonable ... as we await further evidence on safety and efficacy of estrogen alone, different routes of administration, lower doses, and ...

Related articles from newspapers, magazines, journals, and more
All estrogen medications get a black box. (Hot Flashes).(Brief Article)
Newspaper article from: A Friend Indeed January 1, 2003 700+ words
...2003, the FDA announced that all drugs containing estrogen or estrogen plus progestin for use by post-menopausal women...benefits with long-term use of Prempro, the combined estrogen with progestin HRT formula most popular in North America...
FDA issues `Black Box' warning based on WHI study.(Food and Drug...
Newspaper article from: Sports Medicine Reports Elliott, William T. February 1, 2003 700+ words
...FDA has mandated a "Black Box" warning for all estrogen and estrogen/progestin...and FDA action, all estrogen products will be subject...risks of lower-dose estrogen products and if other types of estrogens and progestins are associated...
Estrogen; Treatment.
Newspaper article from: NWHRC Health Center - Estrogen March 16, 2005 700+ words
...versions of the combination estrogen-progestin treatment sold...highlighted (boxed) warning on all estrogen products for use by postmenopausal women. The so-called "black box" is the strongest step the...professionals to prescribe estrogen products at the lowest dose...
Researchers Find Novel Mechanism to Predict Survival in Older Women With Early...
News wire article from: Ascribe Higher Education News Service October 31, 2007 700+ words
...researchers showed that either estrogen or aromatase triggered the...had shown that the hormone estrogen had a major impact on lung...these data into an unbiased black box and discovered these novel...as starting material to make estrogen. The cancer may be devising...
Options when estrogen-containing contraception is...
Magazine article from: Clinical Advisor Stern, Lisa July 1, 2009 700+ words
...safe in perimenopausal women for whom estrogen-containing contraceptives are contraindicated...mass. With the FDA's issuance of a black-box warning in 2004, many providers became...pills, can be used by women in whom estrogen is contraindicated and provide similar...
Black Box Network Services Launches Nortel Customer Assurance Program.
Newspaper article from: Biotech Week September 30, 2009 700+ words
Black Box Corporation (NASDAQ: BBOX), an industry...receive a high level of support and service from Black Box Network Services. Under this program, the Solutions Group at Black Box Network Services will commit to install and maintain...
Black Box Resale Enhances In-House Capabilities in Conjunction with Its Nortel...
Press release article from: Business Wire October 6, 2009 700+ words
...about their Nortel Customer Assurance Program, Black Box Corporation (NASDAQ:BBOX), an industry...equipment to the highest standards through its Black Box Resale Services division. Black Box Resale Services' extensive capabilities provides...
Black Box Attains ISO/IEC 20000-1:2005 Certification.
Press release article from: Business Wire May 29, 2009 700+ words
Black Box Network Services Receives Certification...International Airport PITTSBURGH -- Black Box Corporation (NASDAQ:BBOX), an industry...at the Miami International Airport. Black Box manages and runs the Network Operations...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA